Healthcare provider profile · identity verified

Mary Moe Trites, MD

Family Practice · SPRING PARK, MN · NPI 1912906017

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	299	72
Lisinopril	Lisinopril	249	61
Levothyroxine Sodium	Levothyroxine Sodium	238	62
Omeprazole	Omeprazole	223	46
Gabapentin	Gabapentin	178	35
Simvastatin	Simvastatin	165	41
Amlodipine Besylate	Amlodipine Besylate	154	39
Metoprolol Succinate	Metoprolol Succinate	150	43
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	149	23
Metformin Hcl	Metformin Hcl	149	28
Hydrochlorothiazide	Hydrochlorothiazide	146	41
Tramadol Hcl	Tramadol Hcl	124	37
Furosemide	Furosemide	122	32
Rosuvastatin Calcium	Rosuvastatin Calcium	110	29
Losartan Potassium	Losartan Potassium	107	28
Eliquis	Apixaban	91	15
Warfarin Sodium	Warfarin Sodium	86	16
Trazodone Hcl	Trazodone Hcl	85	19
Potassium Chloride	Potassium Chloride	82	19
Atenolol	Atenolol	81	19
Metoprolol Tartrate	Metoprolol Tartrate	80	21
Sertraline Hcl	Sertraline Hcl	77	16
Lorazepam	Lorazepam	72	14
Pantoprazole Sodium	Pantoprazole Sodium	66	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	11
Fluoxetine Hcl	Fluoxetine Hcl	56	13
Albuterol Sulfate Hfa	Albuterol Sulfate	52	21
Famotidine	Famotidine	52	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	50	13
Amoxicillin	Amoxicillin	49	33
Prednisone	Prednisone	49	35
Oxycodone Hcl	Oxycodone Hcl	48	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Allopurinol	Allopurinol	47	12
Ventolin Hfa	Albuterol Sulfate	47	13
Alprazolam	Alprazolam	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	43	12
Bupropion Hcl Sr	Bupropion Hcl	42	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	25
Montelukast Sodium	Montelukast Sodium	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Baclofen	Baclofen	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Glipizide	Glipizide	27	suppressed
Creon	Lipase/Protease/Amylase	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Fluconazole	Fluconazole	19	11
Megestrol Acetate	Megestrol Acetate	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Cephalexin	Cephalexin	18	15
Chlorthalidone	Chlorthalidone	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Morphine Sulfate	Morphine Sulfate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Azithromycin	Azithromycin	16	16
Bupropion Hcl	Bupropion Hcl	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Drospirenone-Ethinyl Estradiol	Ethinyl Estradiol/Drospirenone	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Ozempic	Semaglutide	13	suppressed
Topiramate	Topiramate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Belsomra	Suvorexant	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Nadolol	Nadolol	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Tri-Sprintec	Norgestimate-Ethinyl Estradiol	12	suppressed
Admelog Solostar	Insulin Lispro	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Diazepam	Diazepam	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Naproxen	Naproxen	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error